Hamilton Lane Advisors LLC Guardant Health, Inc. Transaction History

Hamilton Lane Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jun 03, 2024	BUY	$20.94 - $38.01 $223,220 - $405,186	10,660 New	10,660 $381,000
Q1 2023 May 28, 2024	BUY	$22.92 - $33.76 $244,327 - $359,881	10,660 New	10,660 $249,000
Q1 2021 May 05, 2021	SELL	$127.04 - $179.1 $3 Million - $4.23 Million	-23,644 Reduced 68.92%	10,660 $1.63 Million
Q1 2020 Apr 27, 2020	SELL	$59.04 - $88.81 $5 Million - $7.51 Million	-84,615 Reduced 71.15%	34,304 $2.39 Million
Q4 2019 Jan 31, 2020	SELL	$59.49 - $82.78 $4.31 Million - $6 Million	-72,470 Reduced 37.87%	118,919 $9.29 Million
Q3 2019 Nov 13, 2019	BUY	$62.59 - $110.3 $12 Million - $21.1 Million	191,389 New	191,389 $12.2 Million

347

120M

793K

1.85M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $4.38B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Hamilton Lane Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Hamilton Lane Advisors LLC with notifications on news.